Privia Health initiated with an Outperform at Macquarie

Macquarie initiated coverage of Privia Health (PRVA) with an Outperform rating and $25 price target Privia is an enduring leader aiding the transformation of the trillion-dollar healthcare industry to value-based care, the analyst tells investors in a research note. Privia has built a lasting business model that will allow it to sustain its growth momentum in the many years ahead, the firm says.